Viewing Study NCT00091104


Ignite Creation Date: 2025-12-24 @ 9:11 PM
Ignite Modification Date: 2025-12-29 @ 6:17 AM
Study NCT ID: NCT00091104
Status: COMPLETED
Last Update Posted: 2012-03-15
First Post: 2004-09-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Cyclophosphamide and Fludarabine Followed by Vaccine Therapy, Gene-Modified White Blood Cell Infusions, and Aldesleukin in Treating Patients With Metastatic Melanoma
Sponsor: National Institutes of Health Clinical Center (CC)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module